Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ullevaal University Hospital | OTHER |
| Karolinska University Hospital | OTHER |
| Rigshospitalet, Denmark | OTHER |
| Zealand University Hospital |
Not provided
Not provided
Not provided
Not provided
Multi center study of six Memory Clinics in four Nordic countries in validating a prognostic diagnostic investigation of qEEG in Mild Cognitive Impairment (MCI). The study is in two parts, the first one is a follow up of a previous study conducted in 2011-2013 and the second half is new recruitment with two years follow up. End points are diagnosis of a dementing disorder, primarily dementia of Alzheimer´s type.
The Nordic Network in Dementia Diagnostics (NIDD) conducted a study in 2011-2013 on qEEG using a method of Statistical Pattern Recognition (SPR) in six academic Memory Clinics in four Nordic countries. In the current study, those from the former study diagnosed either with Mild Cognitive Impairment (MCI; n= 120) or with Subjective Cognitive Impairment (SCI; n=60) are contacted again and evaluated for cognitive impairment. The EEG registered at entry in the former study is considered in relation to their current diagnosis (SCI,MCI or dementia) and thereby, the prognostic value of the method is evaluated.
In the second part of the study (n=120), new patients evaluated in the Memory Clinics and diagnosed with MCI (not SCI) are invited to participate for a two year follow up.
In the diagnostic work-up, simple screening tests and information from a close relative form the basis of the cognitive status (SCI;MCI, Dementia). In evaluating the cause of cognitive impairment, detailed neuropsychological testing is performed as well as MRI of the brain and CSF for Alzheimer´s markers. qEEG with SPR analysis is registered but the clinician is blinded to its outcome.
The end point in both parts of the study is a diagnosis of a dementing disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Retrospective MCI cohort | EEG with SPR analysis of the group from the study 2011-2013 is evaluated in relation to the status of current cognitive impairment |
| |
| Prospective MCI cohort | New individuals diagnosed with MCI. EEG with SPR analysis is performed during the diagnostic work-up and evaluated in relation to changes in cognitive status during the following two years. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EEG with SPR analysis | Diagnostic Test | qEEG with SPR analysis was performed in group 1 during 2011-2013 and in group 2, the same procedure is performed. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Diagnosis of dementia | The type of dementia is registered | Group 1: 4-6 years after initial registration, Group 2: 1-2 years after initial registration |
| Measure | Description | Time Frame |
|---|---|---|
| CERAD ten word test | Immediate recall (0-30 words); delayed recall (0-10words) and recognition (0-20 words) | Group 1: 4-6 years after initial registration, Group 2: 1-2 years after initial registration |
Not provided
Inclusion Criteria:
Group 1: Individuals diagnosed with either SCI or MCI during 2011-2013 Group 2: Individuals diagnosed with MCI at entry of the study
-
Exclusion Criteria:
Not provided
Not provided
Individuals referred for diagnostic evaluation to an academic Memory Clinic (MC) in either of the six participating centers.
Group 1: Individuals diagnosed with either SCI or MCI in a study by the same centers in 2011-2013 Group 2: Individuals referred to the same academic MC, diagnosed with the cognitive status of MCI at the first visit. They are followed up for 2 years for evaluation of their cognitive status and if diagnosed with dementia, their disorder is registered.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jon Snaedal, MD | Contact | +354 864 0478 | jsnaedal@landspitali.is | |
| Halla Arnardottir, RN | Contact | 354 543 5711 | hallarn@landspitali.is |
| Name | Affiliation | Role |
|---|---|---|
| Knut Engedal, PhD | Ullevaal University Hospital. Oslo, Norway | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Landspitali University Hospital | Recruiting | Reykjavik | Iceland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| D020961 | Lewy Body Disease |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D020734 | Parkinsonian Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D004569 | Electroencephalography |
| ID | Term |
|---|---|
| D003943 | Diagnostic Techniques, Neurological |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D004568 | Electrodiagnosis |
Not provided
Not provided
| OTHER |
| Haukeland University Hospital | OTHER |
| Kavli Research Foundation, Bergen Norway | UNKNOWN |
Not provided
Not provided
Not provided
Whole blood for ApoE status CSF with Alzheimer markers
| D001480 |
| Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D003704 | Dementia |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |